Articles

Well before Operation Warp Speed delivers products en masse, we need to be prepared to distribute them effectively.

Three budding experts have been awarded support for projects aimed at improving the lives of older adults facing Alzheimer’s and dementia.

The project will focus on physician consolidation, surprise billing, out-of-pocket spending and policies to address healthcare prices.

Jakub Hlavka discusses numerous approaches to increase access to cell- and gene-therapies and how political will is essential to realize improvements in healthcare on the Essentially Medicine podcast.

As a kidney doctor and health policy researcher, I am appalled that patients have become a bargaining chip in a game that could result in massive dialysis shortages, increased costs, and death.

Since 2012, the Schaeffer Center has received $6.1 million in funding from the NIH to fund pilot projects by junior scholars focused on addressing disparities. This year we are seeking junior scientists concentrating on Alzheimer’s disease and related dementias in minority populations.

About 12% of insurers’ U.S. spending on in- and out-of-network medical care goes to six types of providers that commonly submit surprise bills.

The cost of medication errors worldwide exceeds $42 billion, or approximately 5%–6% of all hospitalizations. There are a number of cost-effective strategies that could be deployed to reduce the quantity of adverse drug events.

Beyond Covid-19, two other health policy issues are poised to feature prominently in the 2020 U.S. elections: what role government should play in ensuring broad health insurance coverage, and how to cope with the lack of competition in many health care provider markets.

Erin Trish, Elizabeth Fowler, and Paul Ginsburg discussed the future of value-based payment models at a recent webinar viewed by over 500 people.